Melanie Penfold BMRS(RT), MBA, Peter Gorayski BSc, BMBS, FRACGP, FRANZCR, Julia Green BMRP, MSc-Res, MBA(Hlth), CMPS, Kelly Skelton MCncrSC, AdvDip En
{"title":"在澳大利亚布拉格质子治疗与研究中心成立消费者咨询小组。","authors":"Melanie Penfold BMRS(RT), MBA, Peter Gorayski BSc, BMBS, FRACGP, FRANZCR, Julia Green BMRP, MSc-Res, MBA(Hlth), CMPS, Kelly Skelton MCncrSC, AdvDip En","doi":"10.1002/jmrs.746","DOIUrl":null,"url":null,"abstract":"<p>The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) established the Bragg Consumer Advisory Group (BCAG) in 2023. The ABCPTR, being the first of its kind in Australia, will offer proton therapy treatment for challenging solid tumours with the potential to reduce radiation-induced side effects. With over 110 Proton Beam Therapy (PBT) centres globally, Australian patients currently can apply to access government funded treatment overseas, however, international travel for treatment presents various, significant challenges. Consumer engagement in healthcare plays a pivotal role in navigating the multifaceted journey of cancer treatment and can complement cancer control strategies by ensuring the practicalities of the cancer journey are realised. The ABCPTR aims to involve consumers in decision-making processes, especially as it prepares to open Australia's first national proton therapy centre. The aim of this commentary is to highlight the importance of involving consumers in cancer care, and to demonstrate how this was done in Australia's first proton therapy centre. To establish a consumer engagement team, ABCPTR utilised existing clinical staff. The team's formation and upskilling were integral to the project's success. The engagement framework was developed based on the five stages of commitment by the Australian Health Research Alliance and Western Australian Health Translation Network. The ABCPTR consumer engagement team successfully created a community engagement framework and upskilled in consumer engagement principles over 9–12 months. An Expression of Interest (EOI) was launched, resulting in the formation of the BCAG comprising of 10 members with diverse backgrounds and experiences. The BCAG has been actively involved in decision-making processes, with a consumer-led chair and co-chair in place. The group's feedback is expected to influence key performance indicators for the centre. The establishment of the BCAG at the ABCPTR emphasises the importance of integrating patient and community perspectives into clinical initiatives. This proactive approach ensures that processes remain patient-centred. The ongoing multi-level consumer engagement strategy aims to shape a more inclusive approach to cancer care in Australia, especially concerning PBT.</p>","PeriodicalId":16382,"journal":{"name":"Journal of Medical Radiation Sciences","volume":"71 S2","pages":"77-81"},"PeriodicalIF":1.8000,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmrs.746","citationCount":"0","resultStr":"{\"title\":\"Establishing a consumer advisory group at the Australian Bragg Centre for Proton Therapy and Research\",\"authors\":\"Melanie Penfold BMRS(RT), MBA, Peter Gorayski BSc, BMBS, FRACGP, FRANZCR, Julia Green BMRP, MSc-Res, MBA(Hlth), CMPS, Kelly Skelton MCncrSC, AdvDip En\",\"doi\":\"10.1002/jmrs.746\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) established the Bragg Consumer Advisory Group (BCAG) in 2023. The ABCPTR, being the first of its kind in Australia, will offer proton therapy treatment for challenging solid tumours with the potential to reduce radiation-induced side effects. With over 110 Proton Beam Therapy (PBT) centres globally, Australian patients currently can apply to access government funded treatment overseas, however, international travel for treatment presents various, significant challenges. Consumer engagement in healthcare plays a pivotal role in navigating the multifaceted journey of cancer treatment and can complement cancer control strategies by ensuring the practicalities of the cancer journey are realised. The ABCPTR aims to involve consumers in decision-making processes, especially as it prepares to open Australia's first national proton therapy centre. The aim of this commentary is to highlight the importance of involving consumers in cancer care, and to demonstrate how this was done in Australia's first proton therapy centre. To establish a consumer engagement team, ABCPTR utilised existing clinical staff. The team's formation and upskilling were integral to the project's success. The engagement framework was developed based on the five stages of commitment by the Australian Health Research Alliance and Western Australian Health Translation Network. The ABCPTR consumer engagement team successfully created a community engagement framework and upskilled in consumer engagement principles over 9–12 months. An Expression of Interest (EOI) was launched, resulting in the formation of the BCAG comprising of 10 members with diverse backgrounds and experiences. The BCAG has been actively involved in decision-making processes, with a consumer-led chair and co-chair in place. The group's feedback is expected to influence key performance indicators for the centre. The establishment of the BCAG at the ABCPTR emphasises the importance of integrating patient and community perspectives into clinical initiatives. This proactive approach ensures that processes remain patient-centred. The ongoing multi-level consumer engagement strategy aims to shape a more inclusive approach to cancer care in Australia, especially concerning PBT.</p>\",\"PeriodicalId\":16382,\"journal\":{\"name\":\"Journal of Medical Radiation Sciences\",\"volume\":\"71 S2\",\"pages\":\"77-81\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2023-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmrs.746\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medical Radiation Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jmrs.746\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Radiation Sciences","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jmrs.746","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
摘要
澳大利亚布拉格质子治疗与研究中心(ABCPTR)于2023年成立了布拉格消费者咨询小组(BCAG)。澳大利亚布拉格质子治疗与研究中心是澳大利亚首家质子治疗中心,将为具有挑战性的实体瘤提供质子治疗,有望减少辐射引起的副作用。目前,全球有超过110家质子束治疗(PBT)中心,澳大利亚患者可以申请到海外接受政府资助的治疗,但国际旅行治疗带来了各种重大挑战。消费者参与医疗保健在多方面的癌症治疗过程中发挥着关键作用,并能通过确保实现癌症治疗过程中的实际需求来补充癌症控制策略。澳大利亚质子治疗中心(ABCPTR)旨在让消费者参与决策过程,尤其是在准备开设澳大利亚首个国家质子治疗中心之际。本评论旨在强调让消费者参与癌症治疗的重要性,并展示澳大利亚首家质子治疗中心是如何做到这一点的。为了建立消费者参与团队,澳大利亚质子治疗中心利用了现有的临床工作人员。该团队的组建和技能提升是项目成功不可或缺的因素。参与框架是根据澳大利亚健康研究联盟(Australian Health Research Alliance)和西澳大利亚健康翻译网络(Western Australian Health Translation Network)的五个承诺阶段制定的。在 9-12 个月的时间里,ABCPTR 消费者参与团队成功创建了社区参与框架,并掌握了消费者参与原则。意向书(EOI)发布后,成立了由 10 名具有不同背景和经验的成员组成的 BCAG。该小组积极参与决策过程,并由消费者担任主席和联合主席。该小组的反馈意见有望影响中心的主要绩效指标。ABCPTR BCAG 的成立强调了将患者和社区观点纳入临床举措的重要性。这种积极主动的方法可确保各项流程始终以患者为中心。目前正在实施的多层次消费者参与战略旨在为澳大利亚的癌症治疗,尤其是肺结核治疗提供更具包容性的方法。
Establishing a consumer advisory group at the Australian Bragg Centre for Proton Therapy and Research
The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) established the Bragg Consumer Advisory Group (BCAG) in 2023. The ABCPTR, being the first of its kind in Australia, will offer proton therapy treatment for challenging solid tumours with the potential to reduce radiation-induced side effects. With over 110 Proton Beam Therapy (PBT) centres globally, Australian patients currently can apply to access government funded treatment overseas, however, international travel for treatment presents various, significant challenges. Consumer engagement in healthcare plays a pivotal role in navigating the multifaceted journey of cancer treatment and can complement cancer control strategies by ensuring the practicalities of the cancer journey are realised. The ABCPTR aims to involve consumers in decision-making processes, especially as it prepares to open Australia's first national proton therapy centre. The aim of this commentary is to highlight the importance of involving consumers in cancer care, and to demonstrate how this was done in Australia's first proton therapy centre. To establish a consumer engagement team, ABCPTR utilised existing clinical staff. The team's formation and upskilling were integral to the project's success. The engagement framework was developed based on the five stages of commitment by the Australian Health Research Alliance and Western Australian Health Translation Network. The ABCPTR consumer engagement team successfully created a community engagement framework and upskilled in consumer engagement principles over 9–12 months. An Expression of Interest (EOI) was launched, resulting in the formation of the BCAG comprising of 10 members with diverse backgrounds and experiences. The BCAG has been actively involved in decision-making processes, with a consumer-led chair and co-chair in place. The group's feedback is expected to influence key performance indicators for the centre. The establishment of the BCAG at the ABCPTR emphasises the importance of integrating patient and community perspectives into clinical initiatives. This proactive approach ensures that processes remain patient-centred. The ongoing multi-level consumer engagement strategy aims to shape a more inclusive approach to cancer care in Australia, especially concerning PBT.
期刊介绍:
Journal of Medical Radiation Sciences (JMRS) is an international and multidisciplinary peer-reviewed journal that accepts manuscripts related to medical imaging / diagnostic radiography, radiation therapy, nuclear medicine, medical ultrasound / sonography, and the complementary disciplines of medical physics, radiology, radiation oncology, nursing, psychology and sociology. Manuscripts may take the form of: original articles, review articles, commentary articles, technical evaluations, case series and case studies. JMRS promotes excellence in international medical radiation science by the publication of contemporary and advanced research that encourages the adoption of the best clinical, scientific and educational practices in international communities. JMRS is the official professional journal of the Australian Society of Medical Imaging and Radiation Therapy (ASMIRT) and the New Zealand Institute of Medical Radiation Technology (NZIMRT).